Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
NCT07332338 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2026-03-23
Summary
REGENECYTE® (HPC, Cord Blood (Hematopoietic Progenitor Cell, Cord Blood)) for treatment in patients with post-COVID.
Conditions
- Post-COVID-19 Condition
- Post-COVID Condition
- Post-COVID Syndrome
- Long COVID
- Chronic Fatigue
- Chronic Fatigue Symptoms
- Fatigue Post Viral
Interventions
- BIOLOGICAL
-
REGENECYTE®
HPC, Cord Blood (Hematopoietic Progenitor Cell, Cord Blood)
Sponsors & Collaborators
-
StemCyte, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
NCT07265349 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
NCT03899298 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Quality of Life Improvements With Cord Blood Plasma
NCT03229785 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia
NCT01019681 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke
NCT01673932 ·Status: UNKNOWN ·Phase: PHASE1
-
Transplantation of Autologously Derived Mitochondria Following Ischemia
NCT02851758 ·Status: RECRUITING ·Phase: NA
-
Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells
NCT05017298 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cell Therapy in Chronic Ischemic Heart Disease
NCT00362388 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Safety and Efficacy of Hemacord HPC, Cord Blood in Subjects With Acute Ischemic Stroke
NCT03735277 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells
NCT01711346 ·Status: COMPLETED ·Phase: PHASE2
-
Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis
NCT02643823 ·Status: UNKNOWN ·Phase: PHASE1
-
Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure
NCT01299324 ·Status: COMPLETED ·Phase: PHASE1
-
EXCELLENT (EXpanded CELL ENdocardiac Transplantation)
NCT02669810 ·Status: COMPLETED ·Phase: PHASE2
-
CAP-1002 in Severe COVID-19 Disease
NCT04338347 ·Status: NO_LONGER_AVAILABLE
-
Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes
NCT03514537 ·Status: SUSPENDED ·Phase: NA
-
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
NCT00365326 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency
NCT00655707 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow Derived Adult Stem Cells for Acute Anterior Myocardial Infarction
NCT00765453 ·Status: COMPLETED ·Phase: NA
-
Bone Marrow Stem Cell Infusion Following a Heart Attack
NCT00268307 ·Status: COMPLETED ·Phase: PHASE1
-
Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.
NCT03059355 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury
NCT04331405 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cultured Red Blood Cells : Life Span in Vivo Study
NCT00929266 ·Status: COMPLETED ·Phase: NA
-
Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
NCT01071577 ·Status: TERMINATED
-
Intrabone Infusion of Umbilical Cord Blood Stem Cells
NCT01711788 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.
NCT06813027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1